Printer Friendly

THE COOPER COMPANIES' STOCKHOLDERS ELECT DIRECTORS AND APPROVE CONVERSION RIGHTS OF PREFERRED STOCK

 FORT LEE, N.J., Sept. 16 /PRNewswire/ -- The stockholders of The Cooper Companies, Inc. (NYSE: COO) elected two new directors at the annual meeting held Sept. 14. The new directors are:
 -- Steven Rosenberg, vice president and chief financial officer of Cooper Life Sciences, Inc. since 1990. From September 1987 through April 1990, Mr. Rosenberg served as president and chief executive officer of Scomel Industries Inc. (an international marketing and consulting group).
 -- Mel Schnell is a senior partner in Mel Schnell & Co. and chairman of the board of Melroc Corporation (futures, options and commodities trading companies), positions he has held for more than 20 years; he has served as vice chairman of the New York Commodities Exchange since March 1988 and as the president and director of Cooper Life Sciences, Inc. since 1989. Mr. Schnell is also a director of Andover Togs, Inc.
 In addition to the new directors listed above, the company's stockholders also re-elected Joseph C. Feghali, Mark A. Filler, Michael H. Kalkstein, Donald Press, Allan E. Rubenstein, M.D. and Robert S. Weiss. Both Mr. Rosenberg and Mr. Schnell were designated as nominees, as was Mr. Press, by the company's largest stockholder, Cooper Life Sciences, Inc., pursuant to an agreement with the company. At the meeting, the stockholders also approved the conversion rights of the company's Series B preferred stock held by Cooper Life Sciences.
 Mr. Feghali has been the chairman of the board of International Consulting and Investment Technologies, Inc. since December 1989. From 1987 through 1989, he served as chairman of the board of Caesar Consulting Services, Inc. From 1978 through 1987, he served as president and chief executive officer of Security Pacific International Bank.
 Mr. Filler has been chief operating officer of UreSil, L.P. (a manufacturer of disposable medical devices) since 1991. From 1989 to 1991, he was a member of the mergers and acquisitions group of The Equity Group (a holding company for companies affiliated with Sam Zell). Prior to that he was an associate at the law fir of Kirkland & Ellis.
 Mr. Kalkstein has been a partner in the law firm of Berliner-Cohen since 1983. He has been on the board of trustees of Opera San Jose since 1984 and has been serving as its president since 1992. Mr. Kalkstein was a member of the Mayor's Task Force on Arts 2020 in San Jose, Calif., and a member of the Governor of California's Special Task Force to implement the Agricultural Labor Relations Act.
 Mr. Press has served as the executive vice president of Broadway Management Co., Inc. (an owner and manager of commercial office buildings) since 1981. Mr. Press, an attorney, is also a principal in Donald Press, P.C. (a law firm) located in New York City.
 Dr. Rubenstein has been the acting chairman of the board of directors since April 1993. He is also the president of MTC Imaging Services Inc. (a medical imaging company founded by him in 1981, providing MRI and CAT scan equipment to hospitals and clinics). Dr. Rubenstein is certified by the American Board of Psychiatry and Neurology and by the American Society for Neuroimaging. He has been on the faculty of the department of neurology at Mt. Sinai School of Medicine in New York City since 1976, and currently is associate professor and director of the Mt. Sinai Neurofibromatosis Research and Treatment Center. Dr. Rubenstein has authored two books on neurofibromatosis and is medical director for the National Neurofibromatosis Foundation.
 Mr. Weiss has been the treasurer and chief financial officer of the company since 1989. Since October 1992, he has also served as a senior vice president; from March 1984 to October 1992 he served as a vice president, and from 1984 through 1990 he served as controller. He served as controller of Cooper Laboratories, Inc. from 1980 until March 1984 and as vice president from March 1983 until March 1984.
 Following the annual meeting, the company's board of directors elected the following officers:
 Name Office
 Allan E. Rubenstein Acting Chairman of the Board
 Steven G. Singer Executive Vice President and Chief Operating
 Officer
 Robert S. Holcombe Senior Vice President and General Counsel
 Robert S. Weiss Senior Vice President, Treasurer and Chief
 Financial Officer
 A. Thomas Bender Senior Vice President, Operations
 Stephen C. Whiteford Vice President and Corporate Controller
 Gregory A. Fryling Vice President, Business Development
 Marvin J. Garrett Vice President, Regulatory Affairs
 Marisa F. Jacobs Secretary and Associate General Counsel
 Mary G. Cowie Assistant Secretary
 -0- 9/16/93
 /NOTE TO EDITORS: The principal subsidiaries of The Cooper Companies, Inc. are CooperVision, Inc., CooperVision Pharmaceuticals, Inc., CooperSurgical, Inc. and Hospital Group of America, Inc.
 /CONTACT: Marisa A. Heine or Peter C. Harkins of D.F. King & Co., Inc. 212-269-5550/
 (COO)


CO: The Cooper Companies, Inc. ST: New Jersey IN: MTC HEA SU: PER

CK-TS -- NY070 -- 2827 09/16/93 16:40 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 16, 1993
Words:808
Previous Article:EVEREST MEDICAL SIGNS PRODUCT SUPPLY AGREEMENT WITH CONMED
Next Article:TRITON ANNOUNCES APPOINTMENT OF TWO NEW BOARD MEMBERS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters